For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and ...

Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned for ...

Please provide your email address to receive an email when new articles are posted on . Flushing and erythema were reduced in patients using erenumab, a CGRP receptor antagonist. Adverse events were ...

I first discovered I had rosacea almost a decade ago, and since then, finding a foundation to cover up my redness and bumps has been tricky. Every option flaked off on my flushed skin, and the redness ...

FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...